MA
CHE icon

MJP Associates’s Chemed CHE Stock Holding History

MJP Associates’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-488
Closed -$265K – 217
2024
Q2 		$265K Sell
488
-1,128
-70% -$646K 0.06% 182
2024
Q1 		$1.04M Buy
1,616
+148
+10% +$89.9K 0.23% 51
2023
Q4 		$858K Sell
1,468
-15
-1% -$8.39K 0.23% 45
2023
Q3 		$770K Buy
+1,483
New +$771K 0.22% 43

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

MJP Associates's CHE Position: Q3 2024 in Review

MJP Associates sold out of Chemed (CHE) in Q3 2024, closing a stake of 488 shares — an estimated $265K sold.

MJP Associates first reported a position in CHE in Q3 2023 and held it in 4 quarters. The position peaked at $1.04M in Q1 2024. 528 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

  • MJP Associates reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
  • MJP Associates sold 488 Chemed shares in Q3 2024, an estimated $265K.
  • MJP Associates first reported a position in Chemed in Q3 2023 and held it in 4 quarters.
  • MJP Associates's Chemed position peaked at $1.04M in Q1 2024.
  • 528 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on MJP Associates's 13F filing for Q3 2024, filed 12 Nov 2024.